These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 31285741)
1. Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico. Cai Y; Mei J; Xiao Z; Xu B; Jiang X; Zhang Y; Zhu Y Hereditas; 2019; 156():20. PubMed ID: 31285741 [TBL] [Abstract][Full Text] [Related]
2. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis. Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030 [TBL] [Abstract][Full Text] [Related]
3. Identification of potential prognostic biomarkers for breast cancer using WGCNA and PPI integrated techniques. Zheng G; Zhang C; Zhong C Ann Diagn Pathol; 2021 Feb; 50():151675. PubMed ID: 33291061 [TBL] [Abstract][Full Text] [Related]
4. Key Genes and Prognostic Analysis in HER2+ Breast Cancer. Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770 [TBL] [Abstract][Full Text] [Related]
5. Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer. Zhou Q; Ren J; Hou J; Wang G; Ju L; Xiao Y; Gong Y J Cancer Res Clin Oncol; 2019 Sep; 145(9):2383-2396. PubMed ID: 31280346 [TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses. Tang D; Zhao X; Zhang L; Wang Z; Wang C J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958 [TBL] [Abstract][Full Text] [Related]
7. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001 [TBL] [Abstract][Full Text] [Related]
8. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis. Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846 [No Abstract] [Full Text] [Related]
9. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis. Wu JR; Zhao Y; Zhou XP; Qin X Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575 [TBL] [Abstract][Full Text] [Related]
10. Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients. Guo L; Zhang K; Bing Z Mol Med Rep; 2017 Dec; 16(6):7967-7978. PubMed ID: 28944917 [TBL] [Abstract][Full Text] [Related]
11. The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis. Nie Y; Huang F; Lou L; Yan J Med Sci Monit; 2022 Feb; 28():e934424. PubMed ID: 35184130 [TBL] [Abstract][Full Text] [Related]
12. Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis. Liu S; Liu X; Wu J; Zhou W; Ni M; Meng Z; Jia S; Zhang J; Guo S; Lu S; Li Y Medicine (Baltimore); 2020 Dec; 99(49):e23153. PubMed ID: 33285689 [TBL] [Abstract][Full Text] [Related]
13. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658 [TBL] [Abstract][Full Text] [Related]
14. Upregulated miR‑203a‑3p and its potential molecular mechanism in breast cancer: A study based on bioinformatics analyses and a comprehensive meta‑analysis. Cai KT; Feng CX; Zhao JC; He RQ; Ma J; Zhong JC Mol Med Rep; 2018 Dec; 18(6):4994-5008. PubMed ID: 30320391 [TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods. Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409 [TBL] [Abstract][Full Text] [Related]
16. Identification of Hub Genes Using Co-Expression Network Analysis in Breast Cancer as a Tool to Predict Different Stages. Fu Y; Zhou QZ; Zhang XL; Wang ZZ; Wang P Med Sci Monit; 2019 Nov; 25():8873-8890. PubMed ID: 31758680 [TBL] [Abstract][Full Text] [Related]
17. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen. Liu R; Guo CX; Zhou HH Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514 [TBL] [Abstract][Full Text] [Related]
18. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages. Amjad E; Asnaashari S; Sokouti B; Dastmalchi S Sci Rep; 2020 Jul; 10(1):10816. PubMed ID: 32616754 [TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis. Zhai Q; Li H; Sun L; Yuan Y; Wang X Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620 [TBL] [Abstract][Full Text] [Related]
20. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis. Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]